Screener
Iovance Biotherapeutics, Inc. IOVA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s total assets?
- Iovance Biotherapeutics, Inc. (IOVA) reported total assets of $915.53M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s total assets changed year-over-year?
- Iovance Biotherapeutics, Inc.'s total assets increased by 0.9% year-over-year, from $907.44M to $915.53M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s total assets has grown at a 3.5% compound annual growth rate (CAGR), from $768.46M to $913.17M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Iovance Biotherapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude